A
Acrivon Therapeutics (ACRV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Acrivon Therapeutics (ACRV)
Acrivon Therapeutics, Inc. is a United States-based is a clinical-stage oncology therapeutics company. The Company provides technologies driving precision-based medicine. It leverages its phosphoproteomics technology called Acrivon Precision Predicti... Read more
- USD8.44
- USD8.88
- USD8.21
- USD13.20
- 38.10%
- --
- 54.47k
- 98.86k
- 226M
- 3.19
- -33.30%
Stock News
5 hours ago
1 Wall Street Analyst Thinks Tesla Stock Is Going to $258. Is It a Buy After a Post-Earnings Pullback?
Yahoo
7 hours ago
Warren Buffett Is in a Selling Mood. What’s Next?
Yahoo
7 hours ago
Weekly Market Outlook: Central Banks And U.S. Earnings. Will The BoJ Hike Rates?
SeekingAlpha
yesterday
Ackman’s Pershing Square USA says IPO is still happening, despite NYSE delay notice
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
